Maresin-1 suppresses imiquimod-induced skin inflammation by regulating IL-23 receptor expression

Abstract The anti-inflammatory effect of omega 3 polyunsaturated fatty acids has been confirmed in various inflammatory disease models. Maresin-1 (MaR1) is a lipid mediator derived from the omega-3 fatty acid docosahexaenoic acid (DHA) that has displayed strong anti-inflammatory effects in various i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Natsuko Saito-Sasaki, Yu Sawada, Emi Mashima, Takashi Yamaguchi, Shun Ohmori, Haruna Yoshioka, Sanehito Haruyama, Etsuko Okada, Motonobu Nakamura
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c2748112d5144559995d02d8385bb8d9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c2748112d5144559995d02d8385bb8d9
record_format dspace
spelling oai:doaj.org-article:c2748112d5144559995d02d8385bb8d92021-12-02T15:07:51ZMaresin-1 suppresses imiquimod-induced skin inflammation by regulating IL-23 receptor expression10.1038/s41598-018-23623-92045-2322https://doaj.org/article/c2748112d5144559995d02d8385bb8d92018-04-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-23623-9https://doaj.org/toc/2045-2322Abstract The anti-inflammatory effect of omega 3 polyunsaturated fatty acids has been confirmed in various inflammatory disease models. Maresin-1 (MaR1) is a lipid mediator derived from the omega-3 fatty acid docosahexaenoic acid (DHA) that has displayed strong anti-inflammatory effects in various inflammatory disease models. However, the effect of topical MaR1 on cutaneous inflammation remains unclear. Therefore, we initially examined the anti-inflammatory effects of topical Maresin-1 using an imiquimod (IMQ)-induced psoriasis-like mouse model of inflammation. Topical MaR1 reduced the ear swelling response as seen in histological findings. RT-PCR and flow cytometry analyses revealed MaR1 had no inhibitory effect on IL-23, but MaR1 suppressed IL-17A production by γδTCRmid+ and CD4+ cells in the skin. These inhibitory effects were also observed in a subcutaneous IL-23-injected psoriasis model. MaR1 downmodulated IL-23 receptor (IL-23R) expression by suppressing retinoic acid-related orphan receptor γt (RORγt) expression and internalization in a clathrin-dependent manner in γδTCRmid+ and CD4+ cells. These results lead to assumptions that topical MaR1 may be a new therapeutic agent for psoriasis and other IL-17-mediated cutaneous inflammatory diseases.Natsuko Saito-SasakiYu SawadaEmi MashimaTakashi YamaguchiShun OhmoriHaruna YoshiokaSanehito HaruyamaEtsuko OkadaMotonobu NakamuraNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-8 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Natsuko Saito-Sasaki
Yu Sawada
Emi Mashima
Takashi Yamaguchi
Shun Ohmori
Haruna Yoshioka
Sanehito Haruyama
Etsuko Okada
Motonobu Nakamura
Maresin-1 suppresses imiquimod-induced skin inflammation by regulating IL-23 receptor expression
description Abstract The anti-inflammatory effect of omega 3 polyunsaturated fatty acids has been confirmed in various inflammatory disease models. Maresin-1 (MaR1) is a lipid mediator derived from the omega-3 fatty acid docosahexaenoic acid (DHA) that has displayed strong anti-inflammatory effects in various inflammatory disease models. However, the effect of topical MaR1 on cutaneous inflammation remains unclear. Therefore, we initially examined the anti-inflammatory effects of topical Maresin-1 using an imiquimod (IMQ)-induced psoriasis-like mouse model of inflammation. Topical MaR1 reduced the ear swelling response as seen in histological findings. RT-PCR and flow cytometry analyses revealed MaR1 had no inhibitory effect on IL-23, but MaR1 suppressed IL-17A production by γδTCRmid+ and CD4+ cells in the skin. These inhibitory effects were also observed in a subcutaneous IL-23-injected psoriasis model. MaR1 downmodulated IL-23 receptor (IL-23R) expression by suppressing retinoic acid-related orphan receptor γt (RORγt) expression and internalization in a clathrin-dependent manner in γδTCRmid+ and CD4+ cells. These results lead to assumptions that topical MaR1 may be a new therapeutic agent for psoriasis and other IL-17-mediated cutaneous inflammatory diseases.
format article
author Natsuko Saito-Sasaki
Yu Sawada
Emi Mashima
Takashi Yamaguchi
Shun Ohmori
Haruna Yoshioka
Sanehito Haruyama
Etsuko Okada
Motonobu Nakamura
author_facet Natsuko Saito-Sasaki
Yu Sawada
Emi Mashima
Takashi Yamaguchi
Shun Ohmori
Haruna Yoshioka
Sanehito Haruyama
Etsuko Okada
Motonobu Nakamura
author_sort Natsuko Saito-Sasaki
title Maresin-1 suppresses imiquimod-induced skin inflammation by regulating IL-23 receptor expression
title_short Maresin-1 suppresses imiquimod-induced skin inflammation by regulating IL-23 receptor expression
title_full Maresin-1 suppresses imiquimod-induced skin inflammation by regulating IL-23 receptor expression
title_fullStr Maresin-1 suppresses imiquimod-induced skin inflammation by regulating IL-23 receptor expression
title_full_unstemmed Maresin-1 suppresses imiquimod-induced skin inflammation by regulating IL-23 receptor expression
title_sort maresin-1 suppresses imiquimod-induced skin inflammation by regulating il-23 receptor expression
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/c2748112d5144559995d02d8385bb8d9
work_keys_str_mv AT natsukosaitosasaki maresin1suppressesimiquimodinducedskininflammationbyregulatingil23receptorexpression
AT yusawada maresin1suppressesimiquimodinducedskininflammationbyregulatingil23receptorexpression
AT emimashima maresin1suppressesimiquimodinducedskininflammationbyregulatingil23receptorexpression
AT takashiyamaguchi maresin1suppressesimiquimodinducedskininflammationbyregulatingil23receptorexpression
AT shunohmori maresin1suppressesimiquimodinducedskininflammationbyregulatingil23receptorexpression
AT harunayoshioka maresin1suppressesimiquimodinducedskininflammationbyregulatingil23receptorexpression
AT sanehitoharuyama maresin1suppressesimiquimodinducedskininflammationbyregulatingil23receptorexpression
AT etsukookada maresin1suppressesimiquimodinducedskininflammationbyregulatingil23receptorexpression
AT motonobunakamura maresin1suppressesimiquimodinducedskininflammationbyregulatingil23receptorexpression
_version_ 1718388414323097600